Docosahexaenoic acid (DHA) is one of the major ingredients of fish oil and has been reported to have anti-inflammatory properties mediated through the GPR120 receptor. Whether cytosolic phospholipase A2 (cPLA2 ) and lipid mediators produced from cPLA2 activation are involved in the anti-inflammatory role of DHA in macrophages has not been reported. We report here that DHA and the GPR120 agonist, GW9508, activate cPLA2 , cyclooxygenase 2 (COX-2) and cause prostaglandin E2 (PGE2) release in a murine macrophage cell line RAW264.7 and in human primary monocyte-derived macrophages. DHA and GW9508 activate cPLA2 via GPR120 receptor, G protein Galphaq and scaffold protein β-arrestin 2. ERK1/2 activation is involved in DHA- and GW9508-induced cPLA2 activation, but not p38 MAPK. The anti-inflammatory role of DHA and GW9508 is in part via activation of cPLA2, COX-2 and production of PGE2 as a cPLA2 inhibitor or a COX-2 inhibitor partially reverses the DHA- and GW9508-induced inhibition of LPS-induced IL-6 secretion. The cPLA2 product, arachidonic acid (AA) and PGE2 also plays anti-inflammatory role. This effect of PGE2 is partially through inhibition of the NFkB signaling pathway and via the EP4 receptor of PGE2 as an EP4 inhibitor or knock down of EP4 partially reverses DHA inhibition of LPS induced IL-6 secretion. Thus, DHA has an anti-inflammatory effect partially through induction of PGE2. This article is protected by copyright. All rights reserved.